GlaxoSmithKline partners with Acurian to recruit patients for two clinical trials

According to Acurian, it utilizes targeted, database-driven patient recruitment methods to help companies meet their clinical trial recruitment goals.

By Editor on Dec 17, 2001

According to Acurian, it utilizes targeted, database-driven patient recruitment methods to help companies meet their clinical trial recruitment goals. The company revealed it has a community of more than 1.3 million people interested in receiving information about new therapies and clinical trials.

"We are pleased to announce this important agreement with GlaxoSmithKline," said Mark Eisenach, CEO of Acurian. "Using our extensive database assets we are able to target patients for clinical trial recruitment efforts at a level of specificity never before available."